Plasma kallistatin is associated with adiposity and cardiometabolic risk in apparently healthy African American adolescents

Metabolism: Clinical and Experimental

Volumn 62, Issue 5, 2013, Pages 642-646

  Zhu, Haidong ^a   Chao, Julie ^b   Kotak, Ishita ^a   Guo, Dehuang ^a   Parikh, Samip J ^a   Bhagatwala, Jigar ^a   Dong, Yutong ^a   Patel, Sagar Y ^a   Houk, Chris ^a   Chao, Lee ^b   Dong, Yanbin ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Inflammation; Lipids; Obesity

Indexed keywords

ADIPONECTIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; KALLIKREIN INHIBITOR; KALLISTATIN PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AFRICAN AMERICAN; ARTICLE; BODY FAT; BODY MASS; CARDIOMETABOLIC RISK; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE;

ADIPOSITY; ADOLESCENT; AFRICAN AMERICANS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; ASYMPTOMATIC DISEASES; CARDIOVASCULAR DISEASES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH; HUMANS; MALE; METABOLIC DISEASES; OBESITY; RISK FACTORS; SERPINS; YOUNG ADULT;

EID: 84876693425     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2012.10.012     Document Type: Article

References (27)

1. G.X. Zhou, L. Chao, and J. Chao Kallistatin: A novel human tissue kallikrein inhibitor. Purification, characterization, and reactive center sequence J Biol Chem 267 36 1992 25873 25880 (Pubitemid 23013990)
2. L.M. Chen, Q. Song, and L. Chao Cellular localization of tissue kallikrein and kallistatin mRNAs in human kidney Kidney Int 48 3 1995 690 697
3. J. Chao, A. Schmaier, and L.M. Chen Kallistatin, a novel human tissue kallikrein inhibitor: levels in body fluids, blood cells, and tissues in health and disease J Lab Clin Med 127 6 1996 612 620 (Pubitemid 26310340)
4. W.C. Wolf, R.A. Harley, and D. Sluce Localization and expression of tissue kallikrein and kallistatin in human blood vessels J Histochem Cytochem 47 2 1999 221 228 (Pubitemid 29053064)
5. W.C. Wolf, R.A. Harley, and D. Sluce Cellular localization of kallistatin and tissue kallikrein in human pancreas and salivary glands Histochem Cell Biol 110 5 1998 477 484 (Pubitemid 28480280)
6. J. Chao, L.M. Chen, and K.X. Chai Expression of kallikrein-binding protein and alpha 1 antitrypsin genes in response to sex hormones, growth, inflammation and hypertension Agents Actions Suppl 38 Pt 1 1992 174 181
7. C.R. Wang, S.Y. Chen, and C.L. Wu Prophylactic adenovirus-mediated human kallistatin gene therapy suppresses rat arthritis by inhibiting angiogenesis and inflammation Arthritis Rheum 52 4 2005 1319 1324
8. J. Chao, H. Yin, and Y.Y. Yao Novel role of kallistatin in protection against myocardial ischemia-reperfusion injury by preventing apoptosis and inflammation Hum Gene Ther 17 12 2006 1201 1213 (Pubitemid 44975137)
9. L. Gao, H. Yin, and R.S. Smith Jr Role of kallistatin in prevention of cardiac remodeling after chronic myocardial infarction Lab Invest 88 11 2008 1157 1166
10. B. Shen, L. Chao, and J. Chao Pivotal role of JNK-dependent FOXO1 activation in downregulation of kallistatin expression by oxidative stress Am J Physiol Heart Circ Physiol 298 3 2010 H1048 H1054
11. B. Shen, M. Hagiwara, and Y.Y. Yao Salutary effect of kallistatin in salt-induced renal injury, inflammation, and fibrosis via antioxidative stress Hypertension 51 5 2008 1358 1365 (Pubitemid 351555950)
12. H. Yin, L. Gao, and B. Shen Kallistatin inhibits vascular inflammation by antagonizing tumor necrosis factor-alpha-induced nuclear factor kappaB activation Hypertension 56 2 2010 260 267
13. B. Shen, L. Gao, and Y.T. Hsu Kallistatin attenuates endothelial apoptosis through inhibition of oxidative stress and activation of Akt-eNOS signaling Am J Physiol Heart Circ Physiol 299 5 2010 H1419 H1427
14. Y. Liu, G. Bledsoe, and M. Hagiwara Depletion of endogenous kallistatin exacerbates renal and cardiovascular oxidative stress, inflammation and organ remodeling Am J Physiol Renal Physiol 2012
15. A.J. Jenkins, J.D. McBride, and A.S. Januszewski Increased serum kallistatin levels in type 1 diabetes patients with vascular complications J Angiogenes Res 2 2010 19
16. J.X. Ma, L.P. King, Z. Yang, R.K. Crouch, L. Chao, and J. Chao Kallistatin in human ocular tissues: reduced levels in vitreous fluids from patients with diabetic retinopathy Curr Eye Res 15 11 1996 1117 1123 (Pubitemid 26395270)
17. H. Zhu, W. Yan, and D. Ge Relationships of cardiovascular phenotypes with healthy weight, at risk of overweight, and overweight in US youths Pediatrics 121 1 2008 115 122
18. W. Bao, S.A. Threefoot, and S.R. Srinivasan Essential hypertension predicted by tracking of elevated blood pressure from childhood to adulthood: The Bogalusa Heart Study Am J Hypertens 8 7 1995 657 665
19. R.S. Strauss, and H.A. Pollack Epidemic increase in childhood overweight, 1986-1998 JAMA 286 22 2001 2845 2848 (Pubitemid 33126927)
20. A.D. Liese, R.B. D'Agostino Jr., and R.F. Hamman The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study Pediatrics 118 4 2006 1510 1518 (Pubitemid 46393797)
21. K.H. Petty, K. Li, and Y. Dong Sex dimorphisms in inflammatory markers and adiposity in African-American youth Int J Pediatr Obes 5 4 2010 327 333
22. Y. Dong, I.S. Stallmann-Jorgensen, and N.K. Pollock A 16-week randomized clinical trial of 2000 international units daily vitamin D3 supplementation in black youth: 25-hydroxyvitamin D, adiposity, and arterial stiffness J Clin Endocrinol Metab 95 10 2010 4584 4591
23. B. Shen, R.S. Smith Jr., and Y.T. Hsu Kruppel-like factor 4 is a novel mediator of Kallistatin in inhibiting endothelial inflammation via increased endothelial nitric-oxide synthase expression J Biol Chem 284 51 2009 35471 35478
24. H.C. Hatcher, J.X. Ma, and J. Chao Kallikrein-binding protein levels are reduced in the retinas of streptozotocin-induced diabetic rats Invest Ophthalmol Vis Sci 38 3 1997 658 664 (Pubitemid 27143137)
25. A. Langsted, J.J. Freiberg, and B.G. Nordestgaard Fasting and nonfasting lipid levels: Influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction Circulation 118 20 2008 2047 2056
26. R. Weiss, M. Harder, and J. Rowe The relationship between nonfasting and fasting lipid measurements in patients with or without type 2 diabetes mellitus receiving treatment with 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors Clin Ther 25 5 2003 1490 1497 (Pubitemid 36677289)
27. J. Chao, and L. Chao Kallistatin in blood pressure regulation transgenic and somatic gene delivery studies Trends Cardiovasc Med 7 8 1997 307 311 (Pubitemid 27495948)